C. Raffanel

发表

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.

P. Glue, R. Clement, R. Sabo, 2000, Hepatology.

A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C

Samir K. Gupta, P. Glue, R. Clement, 2000 .

Impaired Fibrinolytic Capacity in Patients with Inflammatory Bowel Disease

J. Gris, J. Schved, P. Aguilar-Martinez, 1990, Thrombosis and Haemostasis.

Pegylated interferon‐α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

Samir K. Gupta, P. Glue, R. Sabo, 2000 .

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.

P. Glue, R. Sabo, S. Gupta, 2000, Clinical pharmacology and therapeutics.

Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic Parameters

J. Gris, R. Gomeni, D. Fabre, 1993, Clinical pharmacokinetics.

[Gastro-omental cystic lymphangiomas. General review and report of two cases (author's transl)].

C. Marty‐Double, G. Godlewski, H. Baumel, 1978, Journal de chirurgie.

[Gastric MALT lymphoma and Helicobacter pylori].

C. Pignodel, J. Bourgaux, J. Balmes, 1996, Gastroenterologie clinique et biologique.

Multiple-Dose Pharmacokinetics of Pefloxacin in Patients with Hepatocellular Deficiency

J. Eledjam, R. Gomeni, F. Gény, 1993, Clinical pharmacokinetics.

[A case of barium-peritoneum with neurological involvement. Importance of barium determination in biological fluids].

P. Allain, H. Baumel, B. Deixonne, 1983, Journal de chirurgie.

Small carcinomas of the pancreas with associated chronic pancreatitis: two case reports.

C. Pignodel, H. Baumel, B. Deixonne, 1989, European Journal of Surgical Oncology.

[EC-cell pancreatic endocrine carcinoma responsible for chronic diarrhea].

C. Pignodel, J. Eledjam, P. Balmès, 1991, Journal de Chirurgie.